{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T17:25:00Z","timestamp":1783704300258,"version":"3.55.0"},"reference-count":55,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T00:00:00Z","timestamp":1597363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2020.01439","type":"journal-article","created":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T15:46:44Z","timestamp":1597420004000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":28,"title":["Management of Patients With Hematologic Malignancies During the COVID-19 Pandemic: Practical Considerations and Lessons to Be Learned"],"prefix":"10.3389","volume":"10","author":[{"given":"Alessandro","family":"Isidori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"de Leval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usama","family":"Gergis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pellegrino","family":"Musto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierluigi","family":"Porcu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,8,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N Engl J Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1101\/2020.02.06.20020974","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/s41375-019-0388-x","article-title":"Infections associated with immunotherapeutic and molecular targeted agents in hematology and oncology. a position paper by the European Conference On Infections In Leukemia (ECIL)","volume":"33","author":"Maschmeyer","year":"2019","journal-title":"Leukemia."},{"key":"B4","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S1470-2045(20)30096-6","article-title":"Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China","volume":"21","author":"Liang","year":"2020","journal-title":"Lancet Oncol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1038\/s41375-020-0836-7","article-title":"COVID-19 in persons with haematological cancers","volume":"34","author":"He","year":"2020","journal-title":"Leukemia."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e351","DOI":"10.1016\/S2352-3026(20)30074-0","article-title":"COVID-19 in a patient with chronic lymphocytic leukaemia","volume":"7","author":"Jin","year":"2020","journal-title":"Lancet Haematol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1111\/bjh.16798","article-title":"Outcome of a patient with refractory Hodgkin's lymphoma on pembrolizumab, infected with SARS-CoV-2","volume":"190","author":"O'Kelly","year":"2020","journal-title":"Br J Haematol."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-020-0931-4","article-title":"COVID-19 outcomes in patients with hematologic disease","author":"Malard","year":"2020","journal-title":"Bone Marrow Transplant."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.retram.2020.06.003","article-title":"CAR T-cell treatment during the COVID-19 pandemic: management strategies and challenges","author":"Hu","year":"2020","journal-title":"Curr Res Transl Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"106353","DOI":"10.1016\/j.leukres.2020.106353","article-title":"Acute leukemia in the time of COVID-19","volume":"92","author":"Gavillet","year":"2020","journal-title":"Leuk Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.bbmt.2020.04.008","article-title":"Chimeric antigen receptor T cell therapy during the COVID-19 Pandemic","volume":"26","author":"Bachanova","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"B12","doi-asserted-by":"publisher","first-page":"100201","DOI":"10.1016\/j.lrr.2020.100201","article-title":"Rewriting the rules for care of MDS and AML patients in the time of COVID-19","volume":"20","author":"Raza","year":"2020","journal-title":"Leuk Res Rep."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000508199","article-title":"Treating leukemia in the time of COVID-19","volume":"11","author":"Paul","year":"2020","journal-title":"Acta Haematol."},{"key":"B14","article-title":"Caring for AML patients during the COVID-19 crisis: an American and Italian experience","author":"Wilde","year":"","journal-title":"Front Oncol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41375-020-0832-y","article-title":"Frequently asked questions regarding SARS-CoV-2 in cancer patients-recommendations for clinicians caring for patients with malignant diseases","volume":"1","author":"von","year":"2020","journal-title":"Leukemia."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1038\/s41375-020-0853-6","article-title":"COVID-19 in persons with chronic myeloid leukaemia","volume":"34","author":"Li","year":"2020","journal-title":"Leukemia."},{"key":"B17","doi-asserted-by":"publisher","first-page":"106366","DOI":"10.1016\/j.leukres.2020.106366","article-title":"Covid-19 infection in therapy-naive patients with B-cell chronic lymphocytic leukemia","volume":"93","author":"Paneesha","year":"2020","journal-title":"Leuk Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"3514","DOI":"10.1158\/1078-0432.CCR-20-1427","article-title":"BTK inhibitors in cancer patients with COVID-19:\u201cThe Winner Will Be the One Who Controls That Chaos\u201d (Napoleon Bonaparte)","volume":"26","author":"Chong","year":"2020","journal-title":"Clin Cancer Res"},{"key":"B19","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.bulcan.2020.04.003","article-title":"COVID-19 and acute lymphoblastic leukemias of children and adolescents: first recommendations of the Leukemia committee of the French Society for the fight against Cancers and Leukemias in children and adolescents (SFCE)","volume":"30","author":"Baruchel","year":"2020","journal-title":"Bull Cancer."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e28409","DOI":"10.1002\/pbc.28409","article-title":"The COVID-19 pandemic: a rapid global response for children with cancer from SIOP, COG, SIOP-E, SIOP-PODC, IPSO, PROS, CCI, and St. Jude global","volume":"13","author":"Sullivan","year":"2020","journal-title":"Pediatr Blood Cancer."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e28400","DOI":"10.1002\/pbc.28400","article-title":"COVID-19 and childhood acute lymphoblastic leukemia","volume":"13","author":"Taub","year":"2020","journal-title":"Pediatr Blood Cancer."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000507690","article-title":"Multiple myeloma in the time of COVID-19","author":"Al Saleh","year":"2020","journal-title":"Acta Haematol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.jgo.2020.04.008","article-title":"Caring for older adults with multiple myeloma during the COVID-19 pandemic: perspective from the international forum for optimizing care of older adults with myeloma","volume":"11","author":"Mian","year":"2020","journal-title":"J Geriatr Oncol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e435","DOI":"10.1016\/S2352-3026(20)30124-1","article-title":"Management of patients with multiple myeloma during the COVID-19 pandemic","volume":"7","author":"Malard","year":"2020","journal-title":"Lancet Haematol."},{"key":"B25","unstructured":"COVID-19 and Acute Myeloid Leukemia: Frequently Asked Questions"},{"key":"B26","unstructured":"COVID-19 Recommendations"},{"key":"B27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1182\/blood-2019-123717","article-title":"Time from diagnosis to treatment does not affect outcome in intensively treated patients with newly diagnosed acute myeloid leukemia","volume":"134","author":"R\u00f6llig","year":"2019","journal-title":"Blood."},{"key":"B28","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1093\/cid\/cix325","article-title":"Dasatinib use and risk of cytomegalovirus reactivation after allogeneic hematopoietic-cell transplantation","volume":"65","author":"Prestes","year":"2017","journal-title":"Clin Infect Dis."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.htct.2020.05.001","article-title":"Managing patients with multiple myeloma during the COVID-19 pandemic: recommendations from an expert panel - ABHH monoclonal gammopathies committe","author":"Hungria","year":"2020","journal-title":"Hematol Transfus Cell Ther."},{"key":"B30","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1111\/imj.14859","article-title":"Australian and New Zealand consensus statement on the management of lymphoma, chronic lymphocytic leukaemia and myeloma during the COVID-19 pandemic","volume":"50","author":"Di Ciaccio","year":"2020","journal-title":"Intern Med J."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1038\/s41375-020-0876-z","article-title":"Management of patients with multiple myeloma in the era of COVID-19 pandemic: a consensus paper from European Myeloma Network (EMN)","volume":"34","author":"Terpos","year":"2020","journal-title":"Leukemia"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International myeloma working group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e456","DOI":"10.1016\/S2352-3026(20)30099-5","article-title":"Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02\/HO95): a multicentre, randomised, open-label, phase 3 study","volume":"7","author":"Cavo","year":"2020","journal-title":"Lancet Haematol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1056\/NEJMoa1611750","article-title":"Lenalidomide, bortezomib, and dexamethasone with transplantation for Myeloma","volume":"376","author":"Attal","year":"2017","journal-title":"N Engl J Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1002\/cncr.26422","article-title":"Early versus delayed autologous transplantation after immunomodulatory agents-based induction therapy in patients with newly diagnosed multiple myeloma","volume":"118","author":"Kumar","year":"2012","journal-title":"Cancer."},{"key":"B36","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.transproceed.2015.12.031","article-title":"Early versus delayed autologous stem cell transplantation and interferon maintenance in multiple myeloma: single-center experience of 18 Years","volume":"48","author":"Remenyi","year":"2016","journal-title":"Transplant Proc."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.1200\/JCO.2015.61.2267","article-title":"Revised international staging system for multiple myeloma: a report from international myeloma working group","volume":"33","author":"Palumbo","year":"2015","journal-title":"J Clin Oncol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.3324\/haematol.2016.148189","article-title":"Geriatric assessment in multiple myeloma patients: validation of the International Myeloma Working Group (IMWG) score and comparison with other common comorbidity scores","volume":"101","author":"Engelhardt","year":"2016","journal-title":"Haematologica."},{"key":"B39","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.1111\/bjh.16874","article-title":"Real-world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID-19 disease) in patients with multiple myeloma receiving systemic anticancer therapy","volume":"190","author":"Cook","year":"2020","journal-title":"Br J Haematol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1111\/bjh.16787","article-title":"Interleukin 6-blockade treatment for severe COVID-19 in two patients with multiple myeloma","volume":"190","author":"Chaidos","year":"2020","journal-title":"Br J Haematol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1182\/bloodadvances.2020001907","article-title":"First case of COVID-19 in a patient with multiple myeloma successfully treated with tocilizumab","volume":"4","author":"Zhang","year":"2020","journal-title":"Blood Adv."},{"key":"B42","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/bjh.16815","article-title":"Covid-19 and myeloma: what are the implications for now and in the future?","volume":"190","author":"Freeman","year":"2020","journal-title":"Br J Haematol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1002\/ajh.25460","article-title":"Diffuse large B-cell lymphoma: 2019 update on diagnosis, risk stratification, and treatment","volume":"94","author":"Liu","year":"2019","journal-title":"Am J Hematol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"6742646","DOI":"10.1155\/2018\/6742646","article-title":"Prognostic significance of blood transfusion in elderly patients with primary diffuse large B-cell lymphoma","volume":"2018","author":"Fan","year":"2018","journal-title":"Biomed Res Int."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1016\/S0140-6736(19)33008-9","article-title":"Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial","volume":"394","author":"Poeschel","year":"2020","journal-title":"Lancet."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1182\/blood.2020006028","article-title":"ILROG emergency guidelines for radiation therapy of hematological malignancies during the COVID-19 pandemic","volume":"135","author":"Yahalom","year":"2020","journal-title":"Blood."},{"key":"B47","doi-asserted-by":"publisher","first-page":"245","DOI":"10.6004\/jnccn.2018.0013","article-title":"NCCN guidelines insights: hodgkin lymphoma, version 1.2018","volume":"16","author":"Hoppe","year":"2018","journal-title":"J Natl Compr Canc Netw."},{"key":"B48","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1056\/NEJMoa1510093","article-title":"Adapted treatment guided by interim PET-CT scan in advanced hodgkin's lymphoma","volume":"374","author":"Johnson","year":"2016","journal-title":"N Engl J Med."},{"key":"B49","doi-asserted-by":"publisher","first-page":"650","DOI":"10.6004\/jnccn.2019.0029","article-title":"NCCN guidelines insights: B-cell lymphomas, version 3.2019","volume":"17","author":"Zelenetz","year":"2019","journal-title":"J Natl Compr Canc Netw."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1182\/blood.2020006288","article-title":"The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19-infected patients","volume":"135","author":"Treon","year":"2020","journal-title":"Blood."},{"key":"B51","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1182\/blood-2017-09-806398","article-title":"iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL","volume":"131","author":"Hallek","year":"2018","journal-title":"Blood."},{"key":"B52","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1056\/NEJMoa1812836","article-title":"Ibrutinib regimens versus chemoimmunotherapy in older patients with untreated CLL","volume":"379","author":"Woyach","year":"2018","journal-title":"N Engl J Med."},{"key":"B53","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S1470-2045(18)30788-5","article-title":"Flinn IW Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial","volume":"20","author":"Moreno","year":"2019","journal-title":"Lancet Oncol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"4732","DOI":"10.1182\/blood-2011-07-365338","article-title":"A 2-step approach to myeloablative haploidentical stem cell transplantation: a phase 1\/2 trial performed with optimized T-cell dosing","volume":"118","author":"Grosso","year":"2011","journal-title":"Blood."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/j.bbmt.2020.04.001","article-title":"Graft cryopreservation does not impact overall survival after allogeneic hematopoietic cell transplantation using post-transplantation cyclophosphamide for graft-versus-host disease prophylaxis","volume":"26","author":"Hamadani","year":"2020","journal-title":"Biol Blood Marrow Transpl"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.01439\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T15:46:47Z","timestamp":1597420007000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.01439\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,14]]},"references-count":55,"alternative-id":["10.3389\/fonc.2020.01439"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2020.01439","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,14]]},"article-number":"1439"}}